-
Taxonomy & unit
-
us-gaap: GBP
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
TC BioPharm (Holdings) plc quarterly/annual Nonoperating Income (Expense) history and change rate from 2022 to 2024.
- TC BioPharm (Holdings) plc Nonoperating Income (Expense) for the quarter ending 31 Mar 2024 was £9.06K, a 99.7% decline year-over-year.
- TC BioPharm (Holdings) plc annual Nonoperating Income (Expense) for 2024 was -£38.3K, a 101% decline from 2023.
- TC BioPharm (Holdings) plc annual Nonoperating Income (Expense) for 2023 was £7.24M, a 20% decline from 2022.
Nonoperating Income (Expense), Quarterly (GBP)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (GBP)
Nonoperating Income (Expense), YoY Annual Change (%)